{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:46:27Z","timestamp":1763016387960},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1038\/sj.bmt.1703916","type":"journal-article","created":{"date-parts":[[2003,5,6]],"date-time":"2003-05-06T11:30:21Z","timestamp":1052220621000},"page":"813-816","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir"],"prefix":"10.1038","volume":"31","author":[{"given":"A","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y-H","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mihalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Peace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Pursell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Wickrema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Jessop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"van Besien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,5,6]]},"reference":[{"key":"BF1703916_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175\u2013181.","journal-title":"N Engl J Med"},{"key":"BF1703916_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.bmt.1703355","volume":"29","author":"A Bacigalupo","year":"2002","unstructured":"Bacigalupo A . Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT). Bone Marrow Transplant 2002; 29: 191\u2013195.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703916_CR3","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","volume":"97","author":"J Storek","year":"2001","unstructured":"Storek J, Dawson MA, Storer B et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97: 3380\u20133389.","journal-title":"Blood"},{"key":"BF1703916_CR4","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood.V88.7.2775.bloodjournal8872775","volume":"88","author":"HD Ottinger","year":"1996","unstructured":"Ottinger HD, Beelen DW, Scheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775\u20132779.","journal-title":"Blood"},{"key":"BF1703916_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev.me.42.020191.001143","volume":"42","author":"JD Meyers","year":"1991","unstructured":"Meyers JD . Prevention and treatment of cytomegalovirus infection. Annu Rev Med 1991; 42: 179\u2013187.","journal-title":"Annu Rev Med"},{"key":"BF1703916_CR6","first-page":"788","volume":"98","author":"K van Besien","year":"2001","unstructured":"van Besien K, Devine S, Wickrema A et al. Fludarabine\u2013melphalan is equivalent to fludarabine\u2013thiotepa-TBI-based conditioning for allogeneic transplantation in advanced hematologic malignancies. Experience in 61 consecutive patients [abstract]. Blood 2001; 98: 788.","journal-title":"Blood"},{"key":"BF1703916_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"S Giralt","year":"2001","unstructured":"Giralt S, Thall PF, Khouri I et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001; 97: 631\u2013637.","journal-title":"Blood"},{"key":"BF1703916_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/oxfordjournals.annonc.a010369","volume":"10","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, van Besien K, Khouri I et al. Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma. Ann Oncol 1999; 10: 527\u2013532.","journal-title":"Ann Oncol"},{"key":"BF1703916_CR9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/sj.bmt.1701016","volume":"20","author":"J Kapelushnik","year":"1997","unstructured":"Kapelushnik J, OR R, Slavin S, Nagler A . A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplant 1997; 20: 1109\u20131110.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BF1703916_CR10","first-page":"2006","volume":"98","author":"M Boeckh","year":"2001","unstructured":"Boeckh M, Storer B, Bensinger W et al. CMV infection and disease after marrow vs PBSC transplantation: results from a randomized trial [abstract]. Blood 2001; 98 (Suppl 1): 2006.","journal-title":"Blood"},{"key":"BF1703916_CR11","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1182\/blood.V99.6.1978","volume":"99","author":"C Junghanss","year":"2002","unstructured":"Junghanss C, Boeckh M, Carter RA et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 2002; 99: 1978\u20131985.","journal-title":"Blood"},{"key":"BF1703916_CR12","first-page":"1661","volume":"21","author":"S Cohen","year":"2002","unstructured":"Cohen S, Fung H, Spielberger R et al. Cytomegalovirus infection and disease in non-myeloablative allogeneic hematopoietic stem cell transplant patients [abstract]. ASCO Proc 2002; 21: 1661.","journal-title":"ASCO Proc"},{"key":"BF1703916_CR13","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1182\/blood.V99.8.3050","volume":"99","author":"P Ljungman","year":"2002","unstructured":"Ljungman P, de la CR, Milpied N et al. Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. Blood 2002; 99: 3050\u20133056.","journal-title":"Blood"},{"key":"BF1703916_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1182\/blood.V99.4.1159","volume":"99","author":"P Reusser","year":"2002","unstructured":"Reusser P, Einsele H, Lee J et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 2002; 99: 1159\u20131164.","journal-title":"Blood"},{"key":"BF1703916_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.bmt.1703648","volume":"30","author":"R Nakamura","year":"2002","unstructured":"Nakamura R, Cortez K, Solomon S et al. High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 235\u2013242.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703916_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2141.1991.tb08007.x","volume":"79","author":"K Atkinson","year":"1991","unstructured":"Atkinson K, Downs K, Golenia M et al. Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: Absence of clinical cytomegalovirus infection. Brit J Haematol 1991; 79: 57\u201362.","journal-title":"Brit J Haematol"},{"key":"BF1703916_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/0003-4819-118-3-199302010-00004","volume":"118","author":"DJ Winston","year":"1993","unstructured":"Winston DJ, Ho WG, Bartoni K et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients: results of a placebo-controlled, double-blind trial. Ann Int Med 1993; 118: 179\u2013184.","journal-title":"Ann Int Med"},{"key":"BF1703916_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/clinids\/24.5.830","volume":"24","author":"AP Limaye","year":"1997","unstructured":"Limaye AP, Bowden RA, Myerson D, Boeckh M . Cytomegalovirus disease occurring before engraftment in marrow transplant recipients. Clin Infect Dis 1997; 24: 830\u2013835.","journal-title":"Clin Infect Dis"},{"key":"BF1703916_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/NEJM198801143180202","volume":"318","author":"JD Meyers","year":"1988","unstructured":"Meyers JD, Reed EC, Shepp DH et al. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 1988; 318: 70\u201375.","journal-title":"N Engl J Med"},{"key":"BF1703916_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.bmt.1700498","volume":"19","author":"HG Prentice","year":"1997","unstructured":"Prentice HG, Gluckman E, Powles RL et al. Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. Bone Marrow Transplant 1997; 19: 129\u2013133.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703916_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1086\/314892","volume":"180","author":"R De la C\u00e1mara","year":"1999","unstructured":"De la C\u00e1mara R, Fernandez-Ranada JM . Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir? J Infect Dis 1999; 180: 571\u2013574.","journal-title":"J Infect Dis"},{"key":"BF1703916_CR22","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1086\/515673","volume":"178","author":"M Boeckh","year":"1998","unstructured":"Boeckh M, Gooley TA, Bowden RA . Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia. J Infect Dis 1998; 178: 1153\u20131157.","journal-title":"J Infect Dis"},{"key":"BF1703916_CR23","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1128\/AAC.43.8.1941","volume":"43","author":"CL Talarico","year":"1999","unstructured":"Talarico CL, Burnette TC, Miller WH et al. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein. Antimicrob Agents Chemother 1999; 43: 1941\u20131946.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1703916_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0140-6736(83)92248-1","volume":"2","author":"E Gluckman","year":"1983","unstructured":"Gluckman E, Lotsberg J, Devergie A et al. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir. Lancet 1983; 2: 706\u2013708.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"BF1703916_CR25","first-page":"5206","volume":"96","author":"S Costa","year":"2000","unstructured":"Costa S, Anaissie E, Badros A et al. High incidence of CMV reactivation without disease following mini-allograft peripheral stem cell transplantation [abstract]. Blood 2000; 96 (Suppl 1): 5206.","journal-title":"Blood"},{"key":"BF1703916_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.bmt.1702778","volume":"27","author":"AO Qamruddin","year":"2001","unstructured":"Qamruddin AO, Oppenheim BA, Guiver M et al. Screening for CMV infection in allogeneic bone marrow transplant recipients using quantitative whole blood PCR method. Bone Marrow Transplant 2001; 27: 301\u2013306.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703916","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:36:19Z","timestamp":1648078579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["BF1703916"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703916","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"9 July 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}